These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37902721)

  • 21. AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.
    Su W; Seymour LW; Cawood R
    Sci Rep; 2023 Dec; 13(1):21670. PubMed ID: 38066084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
    Shiau AL; Liu PS; Wu CL
    J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High throughput production, screening and analysis of adeno-associated viral vectors.
    Drittanti L; Rivet C; Manceau P; Danos O; Vega M
    Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
    Cao L; Liu Y; During MJ; Xiao W
    J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient production of adeno-associated virus vectors using split-type helper plasmids.
    Ogasawara Y; Urabe M; Kogure K; Kume A; Colosi P; Kurtzman GJ; Ozawa K
    Jpn J Cancer Res; 1999 Apr; 90(4):476-83. PubMed ID: 10363588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role for highly regulated rep gene expression in adeno-associated virus vector production.
    Li J; Samulski RJ; Xiao X
    J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
    Chadeuf G; Ciron C; Moullier P; Salvetti A
    Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
    Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
    Urabe M; Ding C; Kotin RM
    Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production.
    Cao M; Zhu H; Bandyopadhyay S; You H; Hermonat PL
    Gene Ther; 2012 Apr; 19(4):418-24. PubMed ID: 21850053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products.
    Vincent KA; Piraino ST; Wadsworth SC
    J Virol; 1997 Mar; 71(3):1897-905. PubMed ID: 9032320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transposase-mediated construction of an integrated adeno-associated virus type 5 helper plasmid.
    Smith RH; Afione SA; Kotin RM
    Biotechniques; 2002 Jul; 33(1):204-6, 208, 210-1. PubMed ID: 12139247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
    Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
    Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
    Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
    J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of an rAAV Producer Cell Line through Synthetic Biology.
    Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
    ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines.
    Toublanc E; Benraiss A; Bonnin D; Blouin V; Brument N; Cartier N; Epstein AL; Moullier P; Salvetti A
    J Gene Med; 2004 May; 6(5):555-64. PubMed ID: 15133766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
    Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
    Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.